Professor Rachel Gibson

Head of School

School of Allied Health Science and Practice

Faculty of Health and Medical Sciences

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Professor Rachel Gibson is the Head of the School of Allied Health Science and Practice at the University of Adelaide. In addition, she is Co-Head of the Cancer Treatment Toxicities Group at the Adelaide Medical School, along with Professor Joanne Bowen and Dr Janet Coller. Prior to this role, Rachel was the inaugural Professor and Dean: Academic in the Division of Health Sciences, University of South Australia.

My Research
Career
Publications
Grants and Funding
Teaching
Supervision
Professional Activities
Contact

Rachel's main research interest is supportive care in cancer. Rachel works with a team of researchers from the fields of pathology, molecular biology, microbiology, and immunology, among others, in the study of toxic effects of chemotherapy on the gut microbiome of cancer patients and the development of clinically diagnosed diarrhea, a manifestation of intestinal mucositis. She is a prolific researcher in this field, and has authored or co-authored over 120 journal articles (including 15 in Supportive Care in Cancer), six book chapters, and 75 abstracts presented at the MASCC Annual Meetings. She has also been a leader in MASCC Study Group initiatives (Mucositis and Oral Care) in developing clinical practice guidelines for the management of mucositis secondary to cancer therapy, including gastrointestinal mucositis. These efforts demonstrate her dedication to promoting supportive care knowledge and practice on a global scale. Rachel is recognized as a skilled communicator among peers, students, business collaborators, and partners, and has been an enthusiastic advocate for Supportive Care in Cancer.

Appointments

Date	Position	Institution name
2019 - ongoing	Inaugural Professor and Director, Allied Health	University of Adelaide
2016 - 2019	Professor (Level E)	University of South Australia
2016 - ongoing	Head of Group	University of Adelaide
2014 - 2015	Associate Professor (Level D)	University of Adelaide
2010 - 2013	Senior Lecturer (Level C)	University of Adelaide
2007 - 2009	Lecturer (Level B)	University of Adelaide
2004 - 2009	Research Fellow	Royal Adelaide Hospital

Awards and Achievements

Date	Type	Title	Institution Name	Country	Amount
2020	Award	University of Adelaide Exceptional Leadership for an Academic	University of Adelaide	Australia	-
2019	Award	Distinguished Service Award Recipient	Multinational Association for Supportive Care in Cancer	United States	-
2013	Scholarship	South Australian Professional Development Scholarship	Department for Science and Training, South Australian Government	Australia	-
2013	Award	Dean's Excellence in Teaching	University of Adelaide, Faculty of Health Sciences	Australia	-
2011	Recognition	Best of the Best- Translational Research-Finalist	Clinical Oncology Society of Australia Annual Scientific Meeting	Australia	-
2010	Recognition	South Australian Marie Claire Young Business Woman of the Year-Finalist	Telstra Business Women's Awards	Australia	-
2004	Fellowship	Post-Doctoral Research Fellowship	Cancer Council of South Australia	Australia	-

Education

Date Institution name Country Title
2004 University of Adelaide Australia Doctor of Philosophy
University of Adelaide Australia Bachelor of Health Sciences (Honours)
Research Interests

Cancer Diagnosis Cancer Therapy

Date	Institution name	Country	Title
2004	University of Adelaide	Australia	Doctor of Philosophy
	University of Adelaide	Australia	Bachelor of Health Sciences (Honours)

Journals

Year	Citation
2024	Smith, M. G., Gibson, R. J., Russo, R. N., Karanicolas, S., & Harvey, A. R. (2024). Examining tools for assessing the impact of chronic pain on emotional functioning in children and young people with cerebral palsy: stakeholder preference and recommendations for modification. Quality of Life Research, 33(8), 2247-2259. DOI Scopus1
2024	Abdalla-Aslan, R., Bonomo, P., Keefe, D., Blijlevens, N., Cao, K., Cheung, Y. T., . . . Nagano, C. (2024). Guidance on mucositis assessment from the MASCC Mucositis Study Group and ISOO: an international Delphi study. eClinicalMedicine, 73, 102675-1-102675-12. DOI
2023	Maddern, A. S., Coller, J. K., Bowen, J. M., & Gibson, R. J. (2023). The Association between the Gut Microbiome and Development and Progression of Cancer Treatment Adverse Effects. Cancers, 15(17), 4301-1-4301-22. DOI Scopus2 Europe PMC1
2023	Delon, L. C., Faria, M., Jia, Z., Johnston, S., Gibson, R., Prestidge, C. A., & Thierry, B. (2023). Capturing and Quantifying Particle Transcytosis with Microphysiological Intestine-on-Chip Models. Small Methods, 7(1), 1-12. DOI Scopus3 WoS1 Europe PMC1
2023	Smith, M. G., Farrar, L. C., Gibson, R. J., Russo, R. N., & Harvey, A. R. (2023). Chronic pain interference assessment tools for children and adults who are unable to self‐report: A systematic review of psychometric properties. Developmental Medicine & Child Neurology, 65(8), 1029-1042. DOI Scopus6 WoS1 Europe PMC4
2023	Korver, S. K., Bowen, J. M., Gibson, R. J., Ball, I. A., Secombe, K. R., Wain, T. J., . . . Coller, J. K. (2023). Advanced statistics identifcation of participant and treatment predictors associated with severe adverse efects induced by fuoropyrimidine‑based chemotherapy. Cancer Chemother Pharmacol, 91(6), 507-521. DOI Scopus1 Europe PMC1
2022	Secombe, K. R., Crame, E. E., Tam, S. Y. J., Wardill, H. R., Gibson, R. J., Coller, J. K., & Bowen, J. M. (2022). Intestinal toll-like receptor 4 knockout alters the functional capacity of the gut microbiome following irinotecan treatment.. Cancer Chemother Pharmacol, 89(2), 275-281. DOI Scopus5 WoS3 Europe PMC4
2022	Delon, L., Gibson, R. J., Prestidge, C. A., & Thierry, B. (2022). Mechanisms of uptake and transport of particulate formulations in the small intestine. Journal of Controlled Release, 343, 584-599. DOI Scopus21 WoS9 Europe PMC4
2021	Vijiaratnam, N., Girges, C., Auld, G., Chau, M., Maclagan, K., King, A., . . . Foltynie, T. (2021). Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' study. BMJ OPEN, 11(5), 11 pages. DOI
2021	Gill, K. K., Gibson, R., Yiu, K. H. C., Hester, P., & Reis, N. M. (2021). Microcapillary film reactor outperforms single-bore mesocapillary reactors in continuous flow chemical reactions. CHEMICAL ENGINEERING JOURNAL, 408, 12 pages. DOI
2020	Gatej, S. M., Bright, R., Weyrich, L. S., Marino, V., Christophersen, C. T., Gibson, R. J., . . . Bartold, P. M. (2020). Probiotic Lactobacillus Rhamnosus GG Protects Against P. Gingivalis And F. Nucleatum Gut Dysbiosis.. Journal of the International Academy of Periodontology, 22(2), 18-27. Europe PMC8
2020	Secombe, K. R., Van Sebille, Y. Z. A., Mayo, B. J., Coller, J. K., Gibson, R. J., & Bowen, J. M. (2020). Diarrhea Induced by Small Molecule Tyrosine Kinase Inhibitors Compared With Chemotherapy: Potential Role of the Microbiome.. Integr Cancer Ther, 19, 1534735420928493. DOI Scopus34 WoS26 Europe PMC25
2020	Elad, S., Cheng, K. K. F., Lalla, R. V., Yarom, N., Hong, C., Logan, R. M., . . . Zur, E. (2020). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, 126(19), 4423-4431. DOI Scopus317 WoS208 Europe PMC159
2019	Pocock, K., Delon, L. C., Khatri, A., Prestidge, C., Gibson, R., Barbe, C., & Thierry, B. (2019). Uptake of silica particulate drug carriers in an intestine-on-a-chip: towards a better in vitro model of nanoparticulate carrier and mucus interactions. Biomaterials Science, 7(6), 2410-2420. DOI Scopus27 WoS22 Europe PMC8
2019	Klisuric, A., Thierry, B., Delon, L., Prestidge, C. A., & Gibson, R. J. (2019). Highlight Article: Identifying human and murine M cells in vitro. Experimental Biology and Medicine, 244(7), 554-564. DOI Scopus7 WoS3 Europe PMC3
2019	Van Sebille, Y. Z., Gibson, R. J., Wardill, H. R., Carney, T. J., & Bowen, J. M. (2019). Use of zebrafish to model chemotherapy and targeted therapy gastrointestinal toxicity.. Experimental biology and medicine (Maywood, N.J.), 244(14), 1178-1185. DOI Scopus15 WoS13 Europe PMC6
2019	Bowen, J. M., Gibson, R. J., Coller, J. K., Blijlevens, N., Bossi, P., Al-Dasooqi, N., . . . Elad, S. (2019). Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines. Supportive Care in Cancer, 27(10), 4011-4022. DOI Scopus57 WoS40 Europe PMC25
2019	Delon, L. C., Guo, Z., Oszmiana, A., Chien, C. C., Gibson, R., Prestidge, C., & Thierry, B. (2019). A systematic investigation of the effect of the fluid shear stress on Caco-2 cells towards the optimization of epithelial organ-on-chip models. Biomaterials, 225, 1-11. DOI Scopus107 WoS56 Europe PMC41
2019	Tam, S. Y. J., Coller, J. K., Wignall, A., Gibson, R. J., Khatri, A., Barbé, C., & Bowen, J. M. (2019). Intestinal accumulation of silica particles in a rat model of dextran sulfate sodium-induced colitis.. Annals of gastroenterology, 32(6), 584-592. DOI Scopus6 WoS4 Europe PMC3
2019	Winter, M., Gibson, R., Ruszkiewicz, A., & Thierry, B. (2019). Cytomorphological Characterization of Individual Metastatic Tumor Cells from Gastrointestinal Cancer Patient Lymph Nodes with Imaging Flow Cytometry. Gastrointestinal Disorders, 1(4), 13 pages. DOI
2019	Korver, S. K., Gibson, R. J., Bowen, J. M., & Coller, J. K. (2019). Toll-like receptor/interleukin-1 domain innate immune signalling pathway genetic variants are candidate predictors for severe gastrointestinal toxicity risk following 5-fluorouracil-based chemotherapy.. Cancer Chemotherapy and Pharmacology, 83(2), 217-236. DOI Scopus4 WoS3 Europe PMC1
2019	Secombe, K. R., Coller, J. K., Gibson, R. J., Wardill, H. R., & Bowen, J. M. (2019). The bidirectional interaction of the gut microbiome and the innate immune system: Implications for chemotherapy‐induced gastrointestinal toxicity. International Journal of Cancer, 144(10), 2365-2376. DOI Scopus56 WoS39 Europe PMC28
2019	Ahmedzai, S. H., Bautista, M. J., Bouzid, K., Gibson, R., Gumara, Y., Hassan, A. A. I., . . . Wang, J. J. (2019). Optimizing cancer pain management in resource-limited settings. Supportive Care in Cancer, 27(6), 2113-2124. DOI Scopus13 WoS12 Europe PMC11
2019	Fakiha, K., Coller, J., Logan, R., Gibson, R., & Bowen, J. (2019). Amitriptyline prevents CPT-11-induced early-onset diarrhea and colonic apoptosis without reducing overall gastrointestinal damage in a rat model of mucositis. Supportive Care in Cancer, 27(6), 2313-2320. DOI Scopus9 WoS7 Europe PMC7
2018	Van Sebille, Y., Gibson, R., Wardill, H., Ball, I., Keefe, D., & Bowen, J. (2018). Dacomitinib-induced diarrhea: Targeting chloride secretion with crofelemer. International Journal of Cancer, 142(2), 369-380. DOI Scopus13 WoS12 Europe PMC10
2018	Gatej, S., Marino, V., Bright, R., Fitzsimmons, T., Gully, N., Zilm, P., . . . Bartold, P. (2018). Probiotic Lactobacillus rhamnosus GG prevents alveolar bone loss in a mouse model of experimental periodontitis. Journal of Clinical Periodontology, 45(2), 204-212. DOI Scopus76 WoS50 Europe PMC33
2018	Gibson, R. J., Van Sebille, Y. Z. A., Wardill, H. R., Wignall, A., Shirren, J., Ball, I. A., . . . Bowen, J. M. (2018). Selective MMP inhibition, using AZD3342, to reduce gastrointestinal toxicity and enhance chemoefficacy in a rat model. Chemotherapy, 63(5), 284-292. DOI Scopus5 WoS5 Europe PMC2
2018	Stansborough, R. L., Al-Dasooqi, N., Bateman, E. H., Bowen, J. M., Keefe, D. M. K., Logan, R. M., . . . Gibson, R. J. (2018). Matrix metalloproteinase expression is altered in the small and large intestine following fractionated radiation in vivo. Supportive Care in Cancer, 26(11), 3873-3882. DOI Scopus7 WoS7 Europe PMC4
2018	Stansborough, R. L., Bateman, E. H., Al-Dasooqi, N., Bowen, J. M., Wignall, A., Keefe, D. M., . . . Gibson, R. J. (2018). Vascular endothelial growth factor (VEGF), transforming growth factor beta (TGFβ), angiostatin, and endostatin are increased in radiotherapy-induced gastrointestinal toxicity. International Journal of Radiation Biology, 94(7), 645-655. DOI Scopus6 WoS4 Europe PMC4
2017	Van Sebille, Y., Gibson, R., Wardill, H., Secombe, K., Ball, I., Keefe, D., . . . Bowen, J. (2017). Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats. International Journal of Cancer, 140(12), 2820-2829. DOI Scopus27 WoS22 Europe PMC20
2017	Stansborough, R. L., & Gibson, R. J. (2017). Proteasome inhibitor-induced gastrointestinal toxicity. Current Opinion in Supportive and Palliative Care, 11(2), 133-137. DOI Scopus18 WoS12 Europe PMC12
2017	Gatej, S., Gully, N., Gibson, R., & Bartold, P. M. (2017). Probiotics and Periodontitis - A Literature Review.. Journal of the International Academy of Periodontology, 19(2), 42-50. Europe PMC16
2017	Al-Dasooqi, N., Bowen, J., Bennett, C., Finnie, J., Keefe, D., & Gibson, R. (2017). Cell adhesion molecules are altered during irinotecan-induced mucositis: a qualitative histopathological study. Supportive Care in Cancer, 25(2), 391-398. DOI Scopus6 WoS5 Europe PMC3
2017	Coller, J. K., Bowen, J. M., Ball, I. A., Wardill, H. R., Van Sebille, Y. Z. A., Stansborough, R. L., . . . Gibson, R. J. (2017). Potential safety concerns of TLR4 antagonism with irinotecan: a preclinical observational report. Cancer Chemotherapy and Pharmacology, 79(2), 431-434. DOI Scopus8 WoS7 Europe PMC6
2017	Williams, B., Tsangari, E., Stansborough, R., Marino, V., Cantley, M., Dharmapatni, A., . . . Crotti, T. (2017). Mixed effects of caffeic acid phenethyl ester (CAPE) on joint inflammation, bone loss and gastrointestinal inflammation in a murine model of collagen antibody-induced arthritis. Inflammopharmacology, 25(1), 55-68. DOI Scopus11 WoS10 Europe PMC6
2017	Wardill, H., Bowen, J., Van Sebille, Y., & Gibson, R. (2017). Routine assessment of the gut microbiome to promote preclinical research reproducibility and transparency. Gut, 66(10), 1869-1871. DOI Scopus3 WoS3 Europe PMC2
2017	Stansborough, R., Bateman, E., Al-Dasooqi, N., Bowen, J., Keefe, D., Yeoh, A., . . . Gibson, R. (2017). Fractionated abdominal irradiation induces intestinal microvascular changes in an in vivo model of radiotherapy-induced gut toxicity. Supportive Care in Cancer, 25(6), 1973-1983. DOI Scopus14 WoS13 Europe PMC12
2016	Wardill, H., Logan, R., Bowen, J., Van Sebille, Y., & Gibson, R. (2016). Tight junction defects are seen in the buccal mucosa of patients receiving standard dose chemotherapy for cancer. Supportive Care in Cancer, 24(4), 1779-1788. DOI Scopus15 WoS13 Europe PMC8
2016	Wardill, H., Mander, K., Van Sebille, Y., Gibson, R., Logan, R., Bowen, J., & Sonis, S. (2016). Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction. International Journal of Cancer, 139(12), 2635-2645. DOI Scopus115 WoS85 Europe PMC69
2016	Wardill, H., Bowen, J., Van Sebille, Y., Secombe, K., Coller, J., Ball, I., . . . Gibson, R. (2016). TLR4-dependent claudin-1 internalization and secretagogue-mediated chloride secretion regulate irinotecan-induced diarrhea. Molecular Cancer Therapeutics, 15(11), 2767-2779. DOI Scopus42 WoS33 Europe PMC19
2016	Gibson, R., Coller, J., Wardill, H., Hutchinson, M., Smid, S., & Bowen, J. (2016). Chemotherapy-induced gut toxicity and pain: involvement of TLRs. Supportive Care in Cancer, 24(5), 2251-2258. DOI Scopus20 WoS20 Europe PMC10
2016	Stansborough, R., Al-dasooqi, N., Bateman, E., Keefe, D., & Gibson, R. (2016). Radiotherapy-induced gut toxicity: involvement of matrix metalloproteinases and the intestinal microvasculature. International Journal of Radiation Biology, 92(5), 241-248. DOI Scopus14 WoS11 Europe PMC8
2016	Wardill, H., Gibson, R., Van Sebille, Y., Secombe, K., Logan, R., & Bowen, J. (2016). A novel in vitro platform for the study of SN38-induced mucosal damage and the development of Toll-like receptor 4-targeted therapeutic options. Experimental Biology and Medicine, 241(13), 1386-1394. DOI Scopus7 WoS7 Europe PMC5
2016	Van Sebille, Y., Gibson, R., Wardill, H., & Bowen, J. (2016). Gastrointestinal toxicities of first and second-generation small molecule human epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer. Current Opinion in Supportive and Palliative Care, 10(2), 152-156. DOI Scopus7 WoS6 Europe PMC5
2016	Wardill, H., Gibson, R., Van Sebille, Y., Secombe, K., Coller, J., White, I., . . . Bowen, J. (2016). Irinotecan-induced gastrointestinal dysfunction and pain are mediated by common TLR4-dependent mechanisms. Molecular Cancer Therapeutics, 15(6), 1376-1386. DOI Scopus110 WoS82 Europe PMC68
2016	Williams, B., Tsangari, E., Stansborough, R., Marino, V., Cantley, M., Dharmapatni, A., . . . Crotti, T. (2016). THE EFFECT OF LOW DOSE CAFFEIC ACID PHENETHYL ESTER ON JOINT INFLAMMATION, BONE LOSS AND GASTROINTESTINAL INFLAMMATION IN A COLLAGEN ANTIBODY-INDUCED ARTHRITIS MURINE MODEL. INTERNAL MEDICINE JOURNAL, 46, 28.
2015	Wardill, H. R., Logan, R. M., Bowen., & Gibson. (2015). Chemotherapy causes tight junction defects in the oral cavity of patients which co-incide with elevated pro inflammatory cytokines and MMPs. Australian Dent, 60(4).
2015	Wardill, H., Van Sebille, Y., Mander, K., Gibson, R., Logan, R., Bowen, J., & Sonis, S. (2015). Toll-like receptor 4 signaling: a common biological mechanism of regimen-related toxicities an emerging hypothesis for neuropathy and gastrointestinal toxicity. Cancer Treatment Reviews, 41(2), 122-128. DOI Scopus32 WoS30 Europe PMC21
2015	Zawawi, M., Perilli, E., Stansborough, R., Marino, V., Cantley, M., Xu, J., . . . Crotti, T. (2015). Caffeic accid phenethyl ester abrogates bone resorption in a murine calvarial model of polyethylene particle-induced osteolysis. Calcified Tissue International, 96(6), 565-574. DOI Scopus20 WoS14 Europe PMC12
2015	Wardill, H. R., Van Sebille, Y. Z., Bowen, J. M., & Gibson, R. J. (2015). Editorial comment: does gut-derived inflammation enhance pain signaling following chemotherapy in a Toll-like receptor 4-dependent manner?. Current Opinion in Supportive and Palliative Care, 9(2), 155-156. DOI Scopus1 WoS1
2015	Van Sebille, Y., Gibson, R., Wardill, H., & Bowen, J. (2015). ErbB small molecule tyrosine kinase inhibitor (TKI) induced diarrhoea: chloride secretion as a mechanistic hypothesis. Cancer Treatment Reviews, 41(7), 646-652. DOI Scopus49 WoS39 Europe PMC30
2015	Gibson, R. J., Bowen, J. M., & Coller, J. K. (2015). What are the predictive factors in the risk and severity of chemotherapy-induced gastrointestinal toxicity?. Future Oncology, 11(17), 2367-2370. DOI Scopus10 WoS9 Europe PMC9
2015	Van Sebille, Y., Stansborough, R., Wardill, H., Bateman, E., Gibson, R., & Keefe, D. (2015). Management of mucositis during chemotherapy: from pathophysiology to pragmatic therapeutics. Current Oncology Reports, 17(11), 50-1-50-8. DOI Scopus62 WoS52 Europe PMC29
2015	Winter, M., Gibson, R., Ruszkiewicz, A., Thompson, S. K., & Thierry, B. (2015). Beyond conventional pathology: towards preoperative and intraoperative lymph node staging. International Journal of Cancer, 136(4), 743-751. DOI Scopus10 WoS10 Europe PMC6
2015	Al-Azri, A. R., Gibson, R. J., Bowen, J. M., Stringer, A. M., Keefe, D. M., & Logan, R. M. (2015). Involvement of matrix metalloproteinases (MMP-3 and MMP-9) in the pathogenesis of irinotecan-induced oral mucositis. Journal of Oral Pathology & Medicine, 44(6), 459-467. DOI Scopus29 WoS28 Europe PMC16
2014	Van Sebille, Y., Gibson, R., & Bowen, J. (2014). IS CROFELEMER AN EFFECTIVE INTERVENTION FOR DACOMITINIB-INDUCED GASTROINTESTINAL TOXICITY?. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 10, 208-209.
2014	Wardill, H., Gibson, R., Logan, R., & Bowen, J. (2014). TLR4/PKC-mediated tight junction modulation: a clinical marker of chemotherapy-induced gut toxicity?. International Journal of Cancer, 135(11), 2483-2492. DOI Scopus31 WoS27 Europe PMC16
2014	Gibson, R. J. (2014). Why continual update of clinical practice guidelines for cytotoxic therapy-induced mucositis is essential. Current Opinion in Supportive and Palliative Care, 8(3), 316-318. DOI
2014	Al-Dasooqi, N., Wardill, H., & Gibson, R. (2014). Gastrointestinal mucositis: the role of MMP-tight junction interactions in tissue injury. Pathology and Oncology Research, 20(3), 485-491. DOI Scopus20 WoS18 Europe PMC12
2014	Wardill, H. R., Bowen, J. M., & Gibson, R. J. (2014). New pharmacotherapy options for chemotherapy-induced alimentary mucositis. Expert Opinion on Biological Therapy, 14(3), 347-354. DOI Scopus15 WoS14 Europe PMC10
2014	Wardill, H., Bowen, J., Al-Dasooqi, N., Sultani, M., Bateman, E., Stansborough, R., . . . Gibson, R. (2014). Irinotecan disrupts tight junction proteins within the gut: implications for chemotherapy-induced gut toxicity. Cancer Biology and Therapy, 15(2), 236-244. DOI Scopus64 WoS53 Europe PMC40
2014	Lalla, R. V., Bowen, J., Barasch, A., Elting, L., Epstein, J., Keefe, D. M., . . . The Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). (2014). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, 120(10), 1453-1461. DOI Scopus830 WoS619 Europe PMC477
2013	Wardill, H., & Gibson, R. (2013). Detecting gut injury during chemotherapy: is a breath test the answer?. Future Oncology, 9(9), 1245-1247. DOI
2013	Al-Dasooqi, N., Sonis, S., Bowen, J., Bateman, E., Blijlevens, N., Gibson, R., . . . Lalla, R. (2013). Emerging evidence on the pathobiology of mucositis. Supportive Care in Cancer, 21(7), 2075-2083. DOI Scopus125 WoS103 Europe PMC71
2013	Wardill, H., Bowen, J., & Gibson, R. (2013). Biomarkers of small intestinal mucosal damage induced by chemotherapy: an emerging role for the 13C sucrose breath test. The Journal of Supportive Oncology, 11(2), 61-67. DOI Scopus12 Europe PMC7
2013	Thorpe, D., Stringer, A., & Gibson, R. (2013). Chemotherapy-induced mucositis: the role of the gastrointestinal microbiome and toll-like receptors. Experimental Biology and Medicine (Maywood), 238(1), 1-6. DOI Scopus31 WoS26 Europe PMC18
2013	Al-Azri, A., Gibson, R., Keefe, D., & Logan, R. (2013). Matrix metalloproteinases: do they play a role in mucosal pahology of the oral cavity?. Oral Diseases, 19(4), 347-359. DOI Scopus19 WoS14 Europe PMC12
2013	Stringer, A., Al-Dasooqi, N., Bowen, J., Tan, T., Radzuan, M., Logan, R., . . . Gibson, R. (2013). Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases. Supportive Care in Cancer, 21(7), 1843-1852. DOI Scopus104 WoS94 Europe PMC74
2013	Gibson, R., Keefe, D., Lalla, R., Bateman, E., Blijlevens, N., Fijlstra, M., . . . Bowen, J. (2013). Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Supportive Care in Cancer, 21(1), 313-326. DOI Scopus175 WoS152 Europe PMC106
2013	Gibson, R. (2013). The urgent need for an effective biomarker for cytotoxic therapy-induced adverse effects. Current Opinion in Supportive and Palliative Care, 7(2), 153-154. DOI Scopus2 WoS2 Europe PMC2
2013	Al-Dasooqi, N., Sonis, S., Bowen, J., Bateman, E., Blijlevens, N., Gibson, R., . . . Lalla, R. (2013). Emerging evidence on the pathobiology of mucositis. Supportive Care in Cancer, 21(11), 3233-3241. DOI Scopus93 WoS76 Europe PMC62
2012	Wardill, H., Bowen, J., & Gibson, R. (2012). Chemotherapy-induced gut toxicity: are alterations to intestinal tight junctions pivotal?. Cancer Chemotherapy and Pharmacology, 70(5), 627-635. DOI Scopus33 WoS32 Europe PMC24
2012	Sultani, M., Stringer, A., Bowen, J., & Gibson, R. (2012). Anti-inflammatory cytokines: important immunoregulatory factors contributing to chemotherapy-induced gastrointestinal mucositis. Chemotherapy Research and Practice, 2012, 1-11. DOI Europe PMC58
2012	Raber-Durlacher, J., Brennan, M., Verdonck-de Leeuw, I., Gibson, R., Eilers, J., Waltimo, T., . . . Spijkervet, F. (2012). Swallowing dysfunction in cancer patients. Supportive Care in Cancer, 20(3), 433-443. DOI Scopus115 WoS91 Europe PMC64
2011	Bowen, J., Gibson, R., & Keefe, D. (2011). Animal models of mucositis: Implications for therapy. The Journal of Supportive Oncology, 9(5), 161-168. DOI Scopus56 Europe PMC37
2011	Gibson, R., & Bowen, J. (2011). Biomarkers of regimen-related mucosal injury. Cancer Treatment Reviews, 37(6), 487-493. DOI Scopus35 WoS33 Europe PMC27
2011	Al-Dasooqi, N., Bowen, J., Gibson, R., Logan, R., Stringer, A., & Keefe, D. (2011). Irinotecan-induced alterations in intestinal cell kinetics and extracellular matrix component expression in the dark agouti rat. International Journal of Experimental Pathology, 92(5), 357-365. DOI Scopus35 WoS30 Europe PMC27
2011	Keefe, D., Bowen, J., Gibson, R., Tan, T., Okera, M., & Stringer, A. (2011). Noncardiac vascular toxicities of vascular endothelial growth factor inhibitors in advanced cancer: a review. The Oncologist, 16(4), 432-444. DOI Scopus82 WoS62 Europe PMC42
2011	Al-Dasooqi, N., Bowen, J., Gibson, R., Logan, R., Stringer, A., & Keefe, D. (2011). Selection of housekeeping genes for gene expression studies in a rat model of irinotecan-induced mucositis. Chemotherapy, 57(1), 43-53. DOI Scopus14 WoS14 Europe PMC10
2010	Al-Dasooqi, N., Gibson, R., Bowen, J., Logan, R., Stringer, A., & Keefe, D. (2010). Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat. Experimental Biology and Medicine (Maywood), 235(10), 1244-1256. DOI Scopus58 WoS48 Europe PMC42
2010	Ong, Z., Gibson, R., Bowen, J., Stringer, A., Darby, J., Logan, R., . . . Keefe, D. (2010). Pro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositis. Radiation Oncology, 5(22), 1-8. DOI Scopus115 WoS100 Europe PMC71
2010	Bowen, J., Tsykin, A., Stringer, A., Logan, R., Gibson, R., & Keefe, D. (2010). Kinetics and regional specificity of irinotecan-induced gene expression in the gastrointestinal tract. Toxicology, 269(1), 1-12. DOI Scopus11 WoS8 Europe PMC7
2010	Al-Dasooqi, N., Gibson, R., Bowen, J., Logan, R., Stringer, A., & Keefe, D. (2010). Matrix metalloproteinases and their inhibitors are altered in a time-course model of irinotecan-induced mucositis. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 25(s3), A2. DOI
2009	Al-Dasooqi, N., Bowen, J., Gibson, R., Sullivan, T., Lees, J., & Keefe, D. (2009). Trastuzumab induces gastrointestinal side effects in HER2-overexpressing breast cancer patients. Investigational New Drugs, 27(2), 173-178. DOI Scopus26 WoS14 Europe PMC14
2009	Stringer, A. M., Gibson, R. J., Bowen, J. M., Logan, R. M., Al-Dasooqi, N., & Keefe, D. M. K. (2009). The importance of the gut microbiome in gastrointestinal mucositis. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, A237.
2009	Stringer, A., Gibson, R., Bowen, J., Logan, R., Ashton, K., Yeoh, A., . . . Keefe, D. (2009). Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile. International Journal of Experimental Pathology, 90(5), 489-499. DOI Scopus123 WoS104 Europe PMC79
2009	Gibson, R., & Stringer, A. (2009). Chemotherapy-induced diarrhoea. Current Opinion in Supportive and Palliative Care, 3(1), 31-35. DOI Scopus62 Europe PMC40
2009	Al-Dasooqi, N., Gibson, R., Bowen, J., & Keefe, D. (2009). HER2 targeted therapies for cancer and the gastrointestinal tract. Current Drug Targets, 10(6), 537-542. DOI Scopus18 WoS17 Europe PMC10
2009	Al-Dasooqi, N., Gibson, R., Bowen, J., & Keefe, D. (2009). Matrix metalloproteinases: key regulators in the pathogenesis of chemotherapy-induced mucositis?. Cancer Chemotherapy and Pharmacology, 64(1), 1-9. DOI Scopus39 WoS37 Europe PMC23
2009	Gibson, R. (2009). Gut microbiome and intestinal mucositis: A new challenge for researchers. Cancer Biology & Therapy, 8(6), 512-513. DOI Scopus10 WoS8 Europe PMC6
2009	Stringer, A., Gibson, R., Logan, R., Bowen, J., Yeoh, A., Hamilton, J., & Keefe, D. (2009). Gastrointestinal Microflora and Mucins May Play a Critical Role in the Development of 5-Fluorouracil-Induced Gastrointestinal Mucositis. Experimental Biology and Medicine (Maywood), 234(4), 430-441. DOI Scopus185 WoS158 Europe PMC106
2009	Stringer, A., Gibson, R., Bowen, J., & Keefe, D. (2009). Chemotherapy-induced modifications to gastrointestinal microflora: Evidence and implications of change. Current Drug Metabolism, 10(1), 79-83. DOI Scopus95 WoS83 Europe PMC60
2009	Stringer, A., Gibson, R., Logan, R., Bowen, J., Yeoh, A., Laurence, J., & Keefe, D. (2009). Irinotecan-induced mucositis is associated with changes in intestinal mucins. Cancer Chemotherapy and Pharmacology, 64(1), 123-132. DOI Scopus69 WoS63 Europe PMC47
2009	Logan, R., Stringer, A., Bowen, J., Gibson, R., Sonis, S., & Keefe, D. (2009). Is the pathobiology of chemotherapy-induced alimentary tract mucositis inXuenced by the type of mucotoxic drug administered?. Cancer Chemotherapy and Pharmacology, 63(2), 239-251. DOI Scopus141 WoS124 Europe PMC93
2008	Logan, R., Gibson, R., Bowen, J., Stringer, A., Sonis, S., & Keefe, D. (2008). Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis. Cancer Chemotherapy and Pharmacology, 62(1), 33-41. DOI Scopus160 WoS142 Europe PMC127
2008	Logan, R., Stringer, A., Bowen, J., Gibson, R., Sonis, S., & Keefe, D. (2008). Serum levels of NF kappa B and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biology & Therapy, 7(7), 1139-1145. DOI Scopus151 WoS124 Europe PMC99
2008	Gibson, R., Bowen, J., & Keefe, D. (2008). Technological advances in mucositis research: New insights and new issues. Cancer Treatment Reviews, 34(5), 476-482. DOI Scopus17 WoS15 Europe PMC8
2008	Stringer, A., Gibson, R., Logan, R., Bowen, J., Yeoh, A., & Keefe, D. (2008). Faecal microflora and β-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats. Cancer Biology & Therapy, 7(12), 1919-1925. DOI Scopus157 WoS125 Europe PMC98
2007	Logan, R., Gibson, R., Sonis, S., & Keefe, D. (2007). Nuclear factor-κ B (NF-κ B) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy. Oral Oncology, 43(4), 395-401. DOI Scopus137 WoS115 Europe PMC97
2007	Bowen, J., Gibson, R., Stringer, A., Chan, T., Prabowo, A., Cummins, A., & Keefe, D. (2007). Role of p53 in irinotecan-induced intestinal cell death and mucosal damage. Anti-Cancer Drugs, 18(2), 197-210. DOI Scopus23 WoS20 Europe PMC16
2007	Stringer, A., Gibson, R., Logan, R., Bowen, J., Yeoh, A., Burns, J., & Keefe, D. (2007). Chemotherapy-induced diarrhea is associated with changes in the luminal environment in the DA rat. Experimental Biology and Medicine (Maywood), 232(1), 96-106. Scopus95 WoS73 Europe PMC47
2007	Bowen, J., Stringer, A., Gibson, R., Yeoh, A., Hannam, S., & Keefe, D. (2007). VSL#3 probiotic treatment reduces chemotherapy-induced diarrhoea and weight loss. Cancer Biology & Therapy, 6(9), 1449-1454. DOI Scopus168 WoS145 Europe PMC98
2007	Keefe, D., Rassias, G., O'Neil, L., & Gibson, R. (2007). Severe mucositis: How can nutrition help?. Current Opinion in Clinical Nutrition and Metabolic Care, 10(5), 627-631. DOI Scopus20 WoS21 Europe PMC16
2007	Stringer, A., Gibson, R., Bowen, J., Logan, R., Yeoh, A., & Keefe, D. (2007). Chemotherapy-induced mucositis: The role of gastrointestinal microflora and mucins in the luminal environment. The Journal of Supportive Oncology, 5(6), 259-267. Scopus71 Europe PMC41
2007	Bowen, J., Gibson, R., Cummins, A., Tyskin, A., & Keefe, D. (2007). Irinotecan changes gene expression in the small intestine of the rat with breast cancer. Cancer Chemotherapy and Pharmacology, 59(3), 337-348. DOI Scopus37 WoS33 Europe PMC24
2007	Logan, R., Stringer, A., Bowen, J., Yeoh, A., Gibson, R., Sonis, S., & Keefe, D. (2007). The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: Pathobiology, animal models and cytotoxic drugs. Cancer Treatment Reviews, 33(5), 448-460. DOI Scopus228 WoS201 Europe PMC160
2007	Bowen, J., Gibson, R., Tsykin, A., Stringer, A., Logan, R., & Keefe, D. (2007). Gene expression analysis of multiple gastrointestinal regions reveals activation of common cell regulatory pathways following cytotoxic chemotherapy. International Journal of Cancer, 121(8), 1847-1856. DOI Scopus40 WoS39 Europe PMC30
2007	Yeoh, A., Gibson, R., Yeoh, E., Bowen, J., Stringer, A., Giam, K., & Keefe, D. (2007). A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis p53 nuclear factor-kappa B COX-1 and COX-2. Molecular Cancer Therapeutics, 6(8), 2319-2327. DOI Scopus51 WoS44 Europe PMC39
2007	Gibson, R., Stringer, A., Bowen, J., Logan, R., Yeoh, A., Burns, J., . . . Keefe, D. (2007). Velafermin improves gastrointestinal mucositis following irinotecan treatment in tumor-bearing DA rats. Cancer Biology & Therapy, 6(4), 541-547. DOI Scopus14 WoS12 Europe PMC7
2007	Gibson, R., Bowen, J., Alvarez, E., Finnie, J., & Keefe, D. (2007). Establishment of a Single-Dose Irinotecan Model of Gastrointestinal Mucositis. Chemotherapy, 53(5), 360-369. DOI Scopus58 WoS45 Europe PMC36
2007	Keefe, D., & Gibson, R. (2007). Mucosal injury from targeted anti-cancer therapy. Supportive Care in Cancer, 15(5), 483-490. DOI Scopus45 WoS33 Europe PMC28
2006	Gibson, R., & Keefe, D. (2006). Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies. Supportive Care in Cancer, 14(9), 890-900. DOI Scopus185 WoS145 Europe PMC114
2006	Bowen, J., Gibson, R., Cummins, A., & Keefe, D. (2006). Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage. Supportive Care in Cancer, 14(7), 713-731. DOI Scopus98 WoS90 Europe PMC66
2006	Bowen, J. M., Gibson, R. J., Cummins, A. G., Tyskin, A., & Keefe, D. M. K. (2006). Irinotecan-induced changes in gene expression in the small intestine of the rat with cancer. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 21, A275.
2006	Stringer, A. M., Gibson, R. J., Logan, R. M., Bowen, J. M., Yeoh, A. S. J., & Keefe, D. M. K. (2006). Chemotherapy-induced changes in mucin secretion and composition. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 21, A266. WoS2
2006	Gibson, R., Cummins, A., Bowen, J., Logan, R., Healey, T., & Keefe, D. (2006). Apoptosis occurs early in the basal layer of the oral mucosa following cancer chemotherapy. Asia Pacific Journal of Clinical Oncology, 2(1), 39-49. DOI Scopus25
2006	Keefe, D., & Gibson, R. (2006). The combination of oral and small intestinal mucositis, pediatrics and biomarkers - A particularly tricky problem!. Cancer Biology & Therapy, 5(10), 1282-1284. DOI Scopus8 WoS8 Europe PMC9
2006	Keefe, D., & Gibson, R. (2006). Sucrose breath testing and intestinal mucositis. Cancer Biology & Therapy, 5(9), 1196-1198. DOI Scopus6 WoS5 Europe PMC4
2006	Yeoh, A., Gibson, R., Yeoh, E., Bowen, J., Stringer, A., Giam, K., . . . Keefe, D. (2006). Radiation therapy-induced mucositis: Relationships between fractionated radiation, NF-kappa B, COX-1, and COX-2. Cancer Treatment Reviews, 32(8), 645-651. DOI Scopus44 WoS38 Europe PMC24
2005	Yeoh, A., Bowen, J., Gibson, R., & Keefe, D. (2005). Nuclear factor kB (NFkB) and cyclooxygenase-2 (Cox-2) expression in the irradiated colorectum is associated with subsequent histopathological changes. International Journal of Radiation Oncology Biology Physics, 63(5), 1295-1303. DOI Scopus77 WoS66 Europe PMC57
2005	Gibson, R., Bowen, J., Cummins, A., & Keefe, D. (2005). Relationship between dose of methotrexate, apoptosis, p53/p21 expression and intestinal crypt proliferation in the rat. Clinical and Experimental Medicine, 4(4), 188-195. DOI Scopus44 WoS37 Europe PMC27
2005	Gibson, R., Bowen, J., & Keefe, D. (2005). Palifermin reduces diarrhea and increases survival following Irinotecan treatment in tumor-bearing DA rats. International Journal of Cancer, 116(3), 464-470. DOI Scopus69 WoS67 Europe PMC44
2005	Bowen, J., Gibson, R., Keefe, D., & Cummins, A. (2005). Cytotoxic chemotherapy upregulates pro-apoptotic Bax and Bak in the small intestine of rats and humans. Pathology, 37(1), 56-62. DOI Scopus73 WoS69 Europe PMC50
2004	Keefe, D., Gibson, R., & Hauer-Jensen, M. (2004). Gastrointestinal mucositis. Seminars in Oncology Nursing, 20(1), 38-47. DOI Scopus93 Europe PMC62
2003	Gibson, R., Bowen, J., Inglis, M., Cummins, A., & Keefe, D. (2003). Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. Journal of Gastroenterology and Hepatology, 18(9), 1095-1100. DOI Scopus167 WoS148 Europe PMC114
2002	Gibson, R., Keefe, D., Thompson, F., Clarke, J., Goland, G., & Cummins, A. (2002). Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats. Digestive Diseases and Sciences, 47(12), 2751-2757. DOI Scopus83 WoS72 Europe PMC56
2002	Gibson, R., Keefe, D., Clarke, J., Regester, G., Thompson, F., Goland, G., . . . Cummins, A. (2002). The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer. Cancer Chemotherapy and Pharmacology, 50(1), 53-58. DOI Scopus90 WoS79 Europe PMC57
2000	Gibson, R., Leigh, C., & Breed, W. (2000). Unusual macromorphology of the ductuli efferentes and epididymis of the koala (Phascolarctos cinereus). Australian Journal of Zoology, 48(6), 681-689. DOI
1993	GIBSON, R. J., MEANOCK, C. I., TORRIE, E. P. H., & WALKER, T. M. (1993). AN ASSESSMENT OF GD-DTPA AS A CT CONTRAST AGENT IN THE RENAL TRACT. CLINICAL RADIOLOGY, 47(4), 278-279. DOI
1991	MASSOUD, T. F., GIBSON, R. J., & NOLAN, D. J. (1991). PERSISTENT COLONIC SPASM - REPLY. CLINICAL RADIOLOGY, 44(5), 363. DOI
1991	MASSOUD, T. F., GIBSON, R. J., & NOLAN, D. J. (1991). PERSISTENT COLONIC SPASM CONCEALING A CARCINOMA - AN UNCOMMON DIAGNOSTIC PITFALL OF THE BARIUM ENEMA EXAMINATION. CLINICAL RADIOLOGY, 43(6), 417-419. DOI
1968	GIBSON, R. J. (1968). EXPERIMENTAL DESIGN OR HAPPINESS IS PLANNING EXPERIMENT. BIOSCIENCE, 18(3), 223-&. DOI

Book Chapters

Year	Citation
2019	Bateman, E., Logan, R., Gibson, R., & Keefe, D. (2019). Mucositis. In R. MacLeod, & L. Van den Block (Eds.), Textbook of Palliative Care (pp. 1-17). Switzerland: Springer Cham.
2013	Gibson, R., Bowen, J., Bateman, E., & Keefe, D. (2013). Biology of treatment-induced mucositis. In A. Berger, J. Shuster, & J. Von Roenn (Eds.), Principles and practice of palliative oncology and supportive oncology (4th ed., pp. 238-246). Lippincott Williams & Wilkins.
2012	Al-Dasooqi, N., Gibson, R., Bowen, J., & Keefe, D. (2012). HER2 targeted therapy-induced gastrointestinal toxicity: from the clinical experience to possible molecular mechanisms. In D. Whitehouse, & R. Rapley (Eds.), Molecular and Cellular Therapeutics (1 ed., pp. 69-102). United Kingdom: Wiley. DOI
2008	Keefe, D., Bowen, J., & Gibson, R. (2008). Use of project teams in preclinical development. In S. Gad (Ed.), Preclinical Development Handbook: Toxicology (pp. 65-80). USA and Canada: Wiley. DOI
2008	Gibson, R., Bowen, J., & Keefe, D. (2008). Relationship between animal models and clinical research: using mucositis as a practical example. In S. Gad (Ed.), Preclinical Development Handbook: Toxicology (pp. 81-101). USA and Canada: Wiley. DOI Scopus1

Conference Papers

Year	Citation
2023	De Coster, D. A., Carroll, M., Lavender, J., & Gibson, R. (2023). A case of Raoultella ornithinolytica cholangitis in a liver transplant recipient. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 38 (pp. 57-58). WILEY.
2018	Secombe, K., Bowen, J., Coller, J., Gibson, R., Stringer, A., Al-Dasooqi, N., . . . Wardill, H. R. (2018). Pre-treatment Blautia abundance regulates chemotherapy-induced gastrointestinal toxicity risk: a pilot study. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 14 (pp. 59). WILEY. WoS1
2018	Korver, S. K., Bowen, J. M., Ball, I. A., Gibson, R. J., Tuke, J., Logan, R., . . . Coller, J. K. (2018). Personalised supportive care for patients receiving 5-fluorouracil (5-FU): analysis of multivariate SNP risk prediction for GI toxicity. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 14 (pp. 58-59). WILEY.
2013	Al-Azri, A. S., Logan, R., Gibson, R., Keefe, D., stringer, A., & Bowen, J. (2013). The role of matrix metalloproteinases and tissue inhibitors of metalloproteinase in irinotecan induced-chemotherapy. In Supportive Care in Cancer. Berlin Genrmany: Springer Verlag (Germany).
2011	Stringer, A., Gibson, R., Yeoh, A., Bowen, J., & Keefe, D. (2011). Chemotherapy-induced diarrhoea is associated with a modified intestinal microbiome and intestinal inflammation. In Abstracts of the 2011 International MASCC/ISOO Symposium Vol. 19 (pp. 153). 175 Fifth Ave New York NY 10010: Springer-Verlag. DOI
2011	Gibson, R., Mahmud, F., Bowen, J., Yeoh, A., Logan, R., & Keefe, D. (2011). Inhibition of NFkB ameliorates long term radiation-induced mucositis. In Proceedings of the 38th COSA Annual Scientific Meeting 2011 Vol. 7 (pp. 110-111). United Kingdom: Blackwell Publishing Ltd.. DOI
2011	Al-Dasooqi, N., Mayo, B., Bowen, J., Stringer, A., Gibson, R., & Keefe, D. (2011). Pilot study of biomarkers of chemotherapy-induced Gastrointestinal Toxicity. In Proceedings of the COSA Annual Scientific Meeting Vol. 7 (pp. 1). United Kingdom: Blackwell Publishing Ltd.. DOI
2010	Al-Dasooqi, N., Bowen, J., Gibson, R., Logan, R., Stringer, A., & Keefe, D. (2010). Irinotecan-induced mucositis encompasses changes in intestinal and colonic cell kinetics and this is associated with altered extracellular matrix component expression. In Abstracts of the 2010 International MASCC/ISOO Symposium Vol. 25 (pp. 0 pages). Vancouver, Canada: Springer-Verlag. DOI
2010	Al-Dasooqi, N., Gibson, R., Bowen, J., Logan, R., Stringer, A., & Keefe, D. (2010). Matrix metalloproteinases play a pivotal role in the development of alimentary tract mucositis. In Sydney Cancer Conference (pp. 0 pages). The University of Sydney, NSW, Australia.
2009	Stringer, A., Gibson, R., Yeoh, A., Bowen, J., Logan, R., & Keefe, D. (2009). CHEMOTHERAPY-INDUCED DIARRHOEA IS ASSOCIATED WITH A MODIFIED MICROBIOME IN GI CANCER PATIENTS. In ANNALS OF ONCOLOGY Vol. 20 (pp. 73). Barcelona, SPAIN: OXFORD UNIV PRESS.
2007	Logan, R., Gibson, R., Stringer, A., Bowen, J., Sonis, S., & Keefe, D. (2007). Nuclear factor-KB and cyclooxygenase-2 expression in the oral mucosa following cancer chemotherapy. In ORAL ONCOLOGY (pp. 171). Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV.
1997	Gibson, R. J. (1997). Machine upset due to plastic cable sheathing. In ANTEC'97 - PLASTICS SAVING PLANET EARTH, CONFERENCE PROCEEDINGS, VOLS 1 - 3 (pp. 1307-1309). CANADA, TORONTO: SOC PLASTICS ENGINEERS.
1995	GIBSON, R. J., & THOMSON, R. D. (1995). THE GENERATION AND EFFECT OF THERMAL TRANSIENTS IN CERAMIC COMPOSITES. In COMPOSITE STRUCTURES Vol. 32 (pp. 435-444). SCOTLAND, UNIV PAISLEY, PAISLEY: ELSEVIER SCI LTD. DOI
1987	WOOD, N. E., GIBSON, R. J., ELDER, A. T., SMYTH, J. F., CROMPTON, G. K., & GREENING, A. P. (1987). PATIENTS WITH SQUAMOUS-CELL BRONCHIAL-CARCINOMA HAVE NORMAL NK CELL NUMBERS BUT ALTERED LYMPHOCYTE-T SUBPOPULATIONS. In CLINICAL SCIENCE Vol. 72 (pp. P52). PORTLAND PRESS.
1987	WOOD, N. E., GIBSON, R. J., ELDER, A. T., SMYTH, J. F., CROMPTON, G. K., & GREENING, A. P. (1987). PATIENTS WITH SQUAMOUS-CELL BRONCHIAL-CARCINOMA HAVE NORMAL NK CELL NUMBERS BUT ALTERED LYMPHOCYTE-T SUBPOPULATIONS. In CLINICAL SCIENCE Vol. 72 (pp. P53). PORTLAND PRESS.

Conference Items

Year	Citation
2019	Coller, J. K., Korver, S. K., Ball, I. A., Gibson, R. J., Tuke, J., Logan, R. M., . . . Bowen, J. M. (2019). Predictors of severe gastrointestinal toxicity risk in patients treated with 5-fluorouracil-based chemotherapy: A validation study. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY.
2017	Korver, S. K., Ball, I. A., Gibson, R. J., Logan, R. M., Karapetis, C. S., Keefe, D. M., . . . Coller, J. K. (2017). The Effect of Immune Genetic Variants on Chemotherapy-Induced Gastrointestinal Toxicity (CIGT) Risk in Patients Receiving 5-Fluorouracil. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY.
2017	Korver, S. K., Ball, I. A., Gibson, R. J., Tuke, J., Logan, R. M., Richards, A., . . . Coller, J. K. (2017). Interleukin-1 Beta (<i>IL1B</i>) Genetic Variability is Predictive of Chemotherapy-Induced Gastrointestinal Toxicity (CIGT) Risk in Patients Receiving 5-Fluorouracil. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY.
2017	Bautista, M. J., Ahmedzai, S. H., Bouzid, K., Gibson, R., Gumara, Y., Hassan, A. A. I., . . . Wang, J. J. (2017). A framework for education and advocacy for optimal cancer pain management in resource-limited settings. Poster session presented at the meeting of Annals of Oncology. Singapore, SINGAPORE: OXFORD UNIV PRESS. DOI
2015	Stansborough, R. L., Bateman, E., Al-Dasooqi, N., Keefe, D., & Gibson, R. (2015). Microvascular injury and associated mediator changes occur during acute radiotherapy-induced gut toxicity. Poster session presented at the meeting of Supportive Care in Cancer. Copenhagen, Denmark: Springer Verlag (Germany).
2009	Stringer, A. M., Gibson, R. J., Bowen, J. M., Logan, R. M., Al-Dasooqi, N., & Keefe, D. M. K. (2009). Chemotherapy-induced diarrhoea is associated with a modified microbiome in cancer patients. Poster session presented at the meeting of Abstracts of the Australia & New Zealand Medical & Surgical Gastrointestinal Week 2009, as published in Journal of Gastroenterology and Hepatology. Sydney, N.S.W.: Wiley-Blackwell. DOI
2000	Gibson, R., Keefe, D., Clarke, J., Regester, G., Edwards, B., Thompson, F., . . . Cummins, A. (2000). Interleukin-11 (IL-11) reduces, but not completely ameliorates, intestinal mucositis following chemotherapy in the rat with breast cancer. Poster session presented at the meeting of Abstracts for Australian Gastroenterology Week 2000. Victoria, Australia: Blackwell Science Asia.

Recorded/Rendered Creative Works

Year	Citation
2015	Authors: Ricci M, Karanicolas, Snelling C, Gibson R, Buisman-Pijlman. Title: Essential Human Biology: Cells and Tissues MOOC. Description: N/A. Extent: 5 weeks.
2015	Authors: Ricci M, Karanicolas, Snelling, Buisman-Pijlman, gibson R. Title: Essential Human Biology: Cells and Tissues YouTube Channel. Description: N/A. Extent: 50 videos.

Theses

Year	Citation
2016	Wardill, H. (2016). Toll-like receptor 4-dependent barrier dysfunction and its impact on irinotecan-induced gut toxicity and pain. (PhD Thesis).
2015	Mohd Rasoul, A. (2015). The expression of matrix metalloproteinases and tissue inhibitor for metalloproteinases in the Keratocystic Odontogenic Tumour. (Master's Thesis).
2013	Al-Azri, A. S. (2013). The role of matrix metalloproteinases and their inhibitors in irinotecan-induced oral mucositis: an animal model. (PhD Thesis, The University of Adelaide).

Date	Project/ No.	Investigators	Funding Body	Amount
2019-2020	Nutritional interventions for chemotherapy-induced gastrointestinal dysfunction in rats with cancer	Bowen JM, Gibson RJ	PanTheryx Pharmaceticals	$190,000.00
2016-2017	Mucositis therapy with AstraZeneca’s AZD1236	Gibson RJ, Bowen JM	Commercial Accelerator Scheme / Open Innovation Scheme	$80,000.00
2015-2019	Improved oral delivery of encapsulated biological agents by targeting epithelial M cells	Prestidge C, Thierry B, Gibson RJ, Khartri A, Barbe C	ARC Linkage Grant	$396,547
2015-2018	A combined pre-clinical and clinical investigation of the role of TLR4 in chemotherapy-induced gut toxicity	Gibson RJ, Bowen JM, Coller JK, Keefe DM	Ray and Shirl Norman Cancer Research Trust	$450,000
2015-2016	Translating concept into practice: enabling first-year health sciences teachers to blueprint effective flipped learning approaches	Karanicolas S, Ricci M Snelling C, Chittleborough C, Chapman J, Douglas T, Williams A, Gamble N, Williams P, Peirce E, Gibson R, Winning T, Milazzo A, Peterson R, Willison J,	Office of Learning and Teaching Australia	$225,000
2015	Abrogating inflammation and bone loss in a mouse model of inflammatory arthritis	Crotti TN, A Dharmapatni, Gibson RJ, Perilli E	Arthritis Australia	$25,000
2014-2015	Determining the underlying mechanisms of gastrointestinal toxicity induced by Oprozomib (invitro)	Gibson RJ	Onyx Pharmaceuticals/Amgen	$112,454
2014-2016	Determining the underlying mechanisms of gastrointestinal toxicity induced by Oprozomib (invivo)	Gibson RJ	Onyx Pharmaceuticals/Amgen	$235,742
2014-2015	Essential Human Biology: Cells and Tissues MOOC (Massive, Open, Online, Course)	Ricci M, Karanicolas S, Buismen-Piljman F, Gibson RJ	University of Adelaide/ AdelaideX	$50,000
2014	Chemotherapy-induced alimentary mucositis: do tight junction disruptions translate from the gut to the oral cavity	Wardill HR, Logan RM, Gibson RJ	Australian Dental Research Foundation	$5200
2013-2014	Novel non-surgical skin cancer therapy using non-themal atmospheric pressure plasma	Kim MK, Gibson R	ECMR Adelaide	$18,655
2013	Flipping the classroom to enhance the first year student experience through the use of interactive learning technologies for student centric learningFlipping the classroom to enhance the first year student experience through the use of interactive learning technologies for student centric learningDVCR – University of Adelaide	Karanicolas S, Snelling C, Ricci M. Peirce E, Gibson R, Winning T, Milazzo A, Peterson R, Willison J	DVC Student Experience – University of Adelaide	$15,000
2012-2013	Automated Immunohistochemistry Machine and PT Link for research	Gibson RJ, Bowen JM, Leigh CM, Roberts C and Butler LM	DVCR – University of Adelaide	$68,500
2012	Are the matrix metalloproteinases and the tissue inhibitors of metalloproteinases upregulated in the oral mucosa following chemotherapy	Al-Azri, A, Gibson RJ, Keefe DMK, Logan RM	Australian Dental Research Foundation	$4000
2011-2012	Validation of a model of colon inflammation (colitis) using ex vivo human colonic mucosal explant tissue as a viable alternative to animal models of colitis	Smid S, Gibson RJ	Medical Advances without Animals	$28,122
2011-2012	South Australian Professional Development Scholarship	Gibson RJ	Department for Science and Technology (South Australian Government)	$15,000
2010-2011	Functional Expression of the Endocannabinoid System in Inflammatory Bowel Disease	Smid S, Gibson RJ, Cummins AG	Broad Medical Research Program	$US128,694
2010-2011	Matrix Metalloproteinases: Key regulators in the pathogenesis of chemotherapy-induced mucositis	Al-Dasooqi N, Gibson RJ, Bowen JM, Keefe, DMK	GlaxoSmithKline	$25,000
2009	Faecal microflora and circulating proinflammatory cytokines: key elements to chemotherapy-induced diarrhoea	Gibson RJ, Bowen JM, Stringer AM, Logan RM	Cancer Australia/Cure Cancer Australia	$75,000
2009	Intestinal Stem Cells	Cummins AG, Roberts-Thomson I, Hardingham J, Gibson RJ	Cancer Council South Australia	$101,000
2009	Faecal microflora and circulating proinflammatory cytokines: key elements to chemotherapy-induced diarrhoea	Gibson RJ	The University of Adelaide, Faculty of Health Sciences Seed Funding	$10,000
2009	Development of the Wistar Rat model for mucositis	Bowen JM and Gibson RJ	The University of Adelaide, ARI seed funding	$26,200
2006	Oral mucositis: clinical presentation, histological features and proinflammatory cytokine expression	Logan RM, Gibson RJ, Keefe DMK and Sonis ST	Australian Dental Research Foundation Inc	$3000
2006	Chemotherapy-induced diarrhoea: Characterisation of Mechanism	Keefe DMK, Gibson RJ, Bowen JM, Stringer AM and Logan RM	Cancer Council South Australia	$70,500
2005	Oral mucositis: relationship between transcription factor expression changes, cytokine expression, apoptosis and subsequent damage	Gibson RJ, Logan RM and Keefe DMK	RAH Research Fund	$19,610
2004-2005	CG53135-05 and chemotherapy-induced intestinal mucositis	Keefe DMK, and Gibson RJ	CuraGen Inc	$US 300,000

Teaching and Training Innovations and Curricula Development

Date	Course
2019-current	Led all curricula development for the launch of three new undergraduate programs at the University of Adelaide: Bachelor of Occupational Therapy (Hons); Bachelor of Physiotherapy (Hons); Bachelor of Speech Pathology (Hons)
2016-2019	Variety of curricula development as Dean: Academic; Division of Health Sciences; University of South Australia. This included Online Bachelor Degree programs; international offshore delivery programs and postgraduate programs
2015-2017	Office of Learning and Teaching Grant: Translating concept into practice: enabling teachers to blueprint flipped learning approaches in first-year health sciences.
2014-2015	MOOC (Mass Online Open Course): Essential Human Biology: Cells and Tissues; Academic Presenter
2013-2014	Flipped Classroom Approach: 1st Year Nursing, University of Adelaide
2009-2011	Year 1 MBBS Convenor, Bachelor of Medicine and Surgery, University of Adelaide
2010-2011	Course Development for Fundamentals of Biomedical Science A and B: 1st Year MBBS, University of Adelaide

Current Higher Degree by Research Supervision (University of Adelaide)

Date	Role	Research Topic	Program	Degree Type	Student Load	Student Name
2024	Principal Supervisor	What impact could greenspace exposure have on lower respiratory outcomes?	Doctor of Philosophy	Doctorate	Part Time	Mrs Amanda Maddern
2021	Principal Supervisor	Tailoring Chronic Pain Assessment to Children and Young People with Cerebral Palsy	Doctor of Philosophy	Doctorate	Full Time	Mrs Meredith Smith
2021	Principal Supervisor	Chronic abdominal pain in Australian adolescents and nature-based intervention	Master of Philosophy (Medical Science)	Master	Part Time	Mrs Trish Serocki

Past Higher Degree by Research Supervision (University of Adelaide)

Date	Role	Research Topic	Program	Degree Type	Student Load	Student Name
2017 - 2021	Co-Supervisor	Exploration of the gut microbiome as a predictive factor for cancer treatment-induced gastrointestinal toxicity	Doctor of Philosophy	Doctorate	Full Time	Miss Kate Rebecca Secombe
2016 - 2020	Co-Supervisor	Identifying potential genetic, phenotypic and epigenetic predictive markers in the Toll-like receptor/Interleukin-1 domain innate immune signalling pathway for severe gastrointestinal toxicity risk following 5-Fluorouracil-based therapy	Doctor of Philosophy	Doctorate	Full Time	Miss Samantha Kaitlyn Korver
2015 - 2018	Co-Supervisor	Clinical and Microbiological Effects of Probiotics in Experimental Induced Periodontitis	Doctor of Philosophy	Doctorate	Full Time	Mrs Simona Gatej
2014 - 2017	Co-Supervisor	Characterisation and Treatment of Pan-Human Epidermal Receptor Tyrosine Kinase Inhibitor-Induced Gastrointestinal Toxicity	Doctor of Philosophy	Doctorate	Full Time	Ysabella Van Sebille
2014 - 2018	Principal Supervisor	Intestinal Microvascular Changes and Matrix Metalloproteinases in Radiotherapy-Induced Gastrointestinal Toxicity	Doctor of Philosophy	Doctorate	Full Time	Romany Laura Stansborough
2013 - 2016	Principal Supervisor	Toll-Like Receptor 4-Dependent Barrier Dysfunction and its Impact on Irinotecan-Induced Gut Toxicity and Pain	Doctor of Philosophy	Doctorate	Full Time	Dr Hannah Rose Wardill
2012 - 2016	Co-Supervisor	Does Transgenic Feed Cause Histopathological Changes in Rats?	Doctor of Philosophy	Doctorate	Full Time	Dr Irena Zdziarski
2010 - 2013	Co-Supervisor	The Role of Matrix Metalloproteinases and their Inhibitors in Irinotecan-Induced Oral Mucositis: An Animal Model	Doctor of Clinical Dentistry	Doctorate	Full Time	APrf Abdul Rahman Al 'Azri
2008 - 2012	Principal Supervisor	Chemotherapy-Induced Mucositis: The Role of Matrix Metalloproteinases and the Extracellular Matrix	Doctor of Philosophy	Doctorate	Full Time	Miss Noor Al-Dasooqi
2006 - 2009	Co-Supervisor	Chemotherapy-Induced Mucositis: The Role of Gastrointestinal Microflora and Mucins in the Luminal Environment	Doctor of Philosophy	Doctorate	Full Time	Dr Andrea Marie Stringer

Board Memberships

Date	Role	Board name	Institution name	Country
2022 - 2024	Member	Multinational Association of Supportive Care in Cancer Board of Directors	Multinational Association of Supportive Care in Cancer	United States
2021 - 2016	Board Member	Multinational Association of Supportive Care in Cancer Board	MASCC	United States
2018 - 2020	Treasurer	Multinational Association of Supportive Care in Cancer	Multinational Association of Supportive Care in Cancer	United States
2016 - 2021	Secretary	Multinational Association of Supportive Care in Cancer	MASCC	United States
2014 - 2016	Board Member	Multinational Association for Supportive Care in Cancer	Multinational Association for Supportive Care in Cancer	United States

Committee Memberships

Date	Role	Committee	Institution	Country
2021 - 2021	Board Member	National Health and Medical Research Council Investigator Grant Panel	National Health and Medical Research Council	Australia
2020 - 2016	Chair	Multinational Association for Supportive Care in Cancer Awards Committee	Multinational Association for Supportive Care in Cancer	United States
2020 - 2020	Member	California Institute for Regenerative Medicine Discovery Stage Program	California Institute for Regenerative Medicine	United States
2020 - 2020	Member	National Health and Medical Research Council Ideas Panel	National Health and Medical Research Council	Australia
2020 - 2020	Member	National Health and Medical Research Council GACD Cancer Prevention Panel	National Health and Medical Research Council	Australia
2019 - 2020	Member	National Health and Medical Research Council Investigtor Panel	National Health and Medical Research Council	Australia
2018 - 2020	Member	California Institute for Regenerative Medicine Discovery Stage Program	California Institute for Regenerative Medicine	United States
2017 - 2017	Member	California Institute for Regenerative Medicine Discovery Stage Program	California Institute for Regenerative Medicine	United States
2016 - ongoing	Member	Project Grants Panel 2C: Endocrinology, Diabetes, Gastroenterology, Musculoskeletal & Obesity	NHMRC	Australia
2016 - ongoing	Advisory Board Member	Therapeutic Goods Assessment and Advisory Services Panel	-	Australia
2016 - ongoing	Secretary	MASCC Board of Directors	Multinational Association for Supportive Care in Cancer	-
2016 - ongoing	Chair	MASCC Annual Scientific Meeting	Multinational Association for Supportive Care in Cancer	-
2014 - 2015	Chair	MASCC Awards Committee	Multinational Association for Supportive Care in Cancer	-
2014 - 2015	Member	MASCC Board of Directors	Multinational Association for Supportive Care in Cancer	-
2014 - 2015	Member	Onyx Pharmaceuticals Oprozomib GI Tolerability Advisory Board	Onyx Pharmaceuticals	United States
2014 - 2015	Member	Project Grants Panel 3A: Endocrinology, Diabetes, Gastroenterology, Musculoskeletal & Obesity	-	Australia
2008 - ongoing	Member	Clinical Oncological Society of Australia (COSA)	-	Australia
2004 - ongoing	Member	Member of the Multinational Association of Supportive Care in Cancer (MASCC)	-	-
2004 - ongoing	Member	International Mucositis Study Group	-	-
2004 - ongoing	Member	International Oral Care Study Group	-	-
2003 - ongoing	Member	Australian Society for Medical Research (ASMR)	-	Australia

Consulting/Advisories

Date	Institution	Department	Organisation Type	Country
2019 - 2020	PanTheryx Pharmaceuticals	RSD	Scientific research	United States
2017 - 2020	Kaleido Biosciences	RSD	Scientific research	United States

Editorial Boards

Date Role Editorial Board Name Institution Country
2016 - ongoing Editor Current Opinion in Supportive and Palliative Care Gastrointestinal Symptoms United Kingdom

Date	Role	Editorial Board Name	Institution	Country
2016 - ongoing	Editor	Current Opinion in Supportive and Palliative Care	Gastrointestinal Symptoms	United Kingdom

Position: Head of School
Phone: 83130245
Email: rachel.gibson@adelaide.edu.au
Campus: North Terrace
Building: Engineering & Maths Sciences, floor 4
Org Unit: Allied Health Administration